Testing biotech Ellume fronts up seeking $500m-plus valuation

SYDNEY: Investors are getting up close and personal with rapid diagnostics company Ellume, ... read more

Former MI6 analyst breathes life into e-health initiative

ADELAIDE: Terry Sweeney’s life-changing moment is clear as day.

He was shot in the ... read more

EQT confirms $2.5bn stake in cancer fighter Icon

BRISBANE: Unlisted cancer treatments network Icon Group has confirmed private equity firm EQT ... read more

Defibrillator play eyes listing on ASX in late 2022

MELBOURNE: Here’s a deal sure to get the heart pumping. Defibrillator developer Rapid ... read more